Dr. Gary Hammer: "The enigma of the adrenal sonic hedgehog progenitor"

~ Eligible for PSL1000H/PSL2000H/PSL4000Y Course Seminar Attendance ~    

Speaker: Dr. Gary Hammer

Millie Schembechler Professor of Adrenal Cancer 
Director – Endocrine Oncology Program 
Professor – Internal Medicine (MEND)
Professor – Cell & Developmental Biology 
Professor – Molecular & Integrative Physiology 
University of Michigan

Biography:

Gary D. Hammer, M.D., Ph.D. is  Professor in Departments of Internal Medicine (MEND), Cell & Developmental Biology, and Molecular & Integrative Physiology.  He currently serves as Director of Endocrine Oncology Programwhere he holds the Millie Schembechler Professorship in Adrenal Cancer. He is past Director of Center for Organogenesis: Stem Cells & Regenerative Medicine. He has brokered the recent renaissance of the current Michigan team of adrenal scientists that includes a who’s who in the study of adrenal disease.  Research projects in his own laboratory are aimed at elucidating the mechanisms by which growth factor signaling and transcriptional programs initiate adrenal-specific  growth and differentiation with an emphasis on dysregulated adrenocortical stem cells in development and  homeostasis with implications for regenerative medicine and neoplasia.  He received the UofM Jerome Conn Award for Outstanding Research in Internal Medicine, the Endocrine Society Edwin B. Astwood Award for Outstanding Research and is a member of ASCI and AAP.  He has served in numerous leadership roles at UofM and in the public and private sectors including recent tenure on Board of Scientific Advisors for NCI.  He has served in numerous capacities for the world’s largest endocrine organization, the Endocrine Society including his most recent role as  President of the Society (2020-2021). An Advisor to the Congressional H.E.L.P. committee  - he co-authored the 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act’’ introduced  in Congress in 2009. He is the editor of four textbooks: Adrenocortical Carcinoma: Basic Science and Clinical Concepts (Springer 2011), Pathophysiology of Disease: An Introduction to Clinical Medicine (Harper Row, 2014; 2018), Genetics Steroid Disorders 2nd edition (Elsevier, 2023) and the Adrenal Section Editor for Degroot’s Endocrinology, 8th edition (Elsevier, 2022). He has been catalyst for the formation of two international cooperative groups, most recently the A5 (American Australian Asian Adrenal Alliance) that leverages collaboration to secure projects from Pharma and funding agencies across the spectrum of adrenal diseases. Such work with colleagues has led to the development of new national and international therapeutic trials with biological-based therapies while sparing normal tissue. He is a co- founder of two companies -  MILLENDO and SLING THERAPEUTICS that focus on rare endocrine diseases.

Website: https://medicine.umich.edu/dept/cancer-biology/gary-hammer-md-phd

Location:  MSB 2170 (in-person only)

Hosted by Denise Belsham

Professor of Physiology
University of Toronto